title: Recommended changes to oncology clinical trial design: revolution or evolution?
authors.affiliation: University of Chicago, Chicago, IL, USA. mratain@medicine.bsd.uchicago.edu
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Ratain
authors.forename: Rachel W
authors.initials: RW
authors.lastname: Humphrey
authors.forename: Gary B
authors.initials: GB
authors.lastname: Gordon
authors.forename: Gwen
authors.initials: G
authors.lastname: Fyfe
authors.forename: Peter C
authors.initials: PC
authors.lastname: Adamson
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Fleming
authors.forename: Walter M
authors.initials: WM
authors.lastname: Stadler
authors.forename: Donald A
authors.initials: DA
authors.lastname: Berry
authors.forename: Carl C
authors.initials: CC
authors.lastname: Peck
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D008495:Medical Oncology